Privium Fund Management (UK) Ltd - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Privium Fund Management (UK) Ltd ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$291,000
-6.7%
29,000
+15.0%
0.33%
+88.6%
Q1 2022$312,000
-32.2%
25,209
+26.0%
0.18%
-51.8%
Q4 2021$460,000
+3.8%
20,0000.0%0.36%
-23.6%
Q3 2021$443,00020,0000.48%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders